1D·

Diabetes Care publishes results from the prevalence phase of Corcept's CATALYST study in people with difficult-to-control type 2 diabetes

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat serious endocrinologic, oncologic, metabolic and neurologic diseases by modulating the effects of the hormone cortisol, today announced the publication of results from the prevalence phase of the CATALYST study in Diabetes Care , a peer-reviewed journal of the American Diabetes Association.

https://www.wallstreet-online.de/nachricht/19251780-diabetes-care-publishes-results-from-prevalence-phase-of-corcept-s-catalyst-trial-people-with-difficult-to-control-type-2-diabetes

attachment

6

10 Comments

investment_guru_2035@investment_guru_2035

1D

Nice share, but already wildly volatile. I just keep on holding 💯

••

Tenbagger2024@Tenbagger2024

1D

@investment_guru_2035
The vola is also currently at 🍊his health minister Kennedy. I'm sticking with it too, nice growth value.

•

1

•

investment_guru_2035@investment_guru_2035

1D

@Tenbagger2024 I think Halozyme $HALO is a similarly beautiful title - I just haven't found the right way to get started yet.

••

Tenbagger2024@Tenbagger2024

1D

@investment_guru_2035
There are some great stocks in the biotech sector.
$TLX are also performing well at the moment.

••

1D

Too bad I don't have any more cash 😒

••

Tenbagger2024@Tenbagger2024

1D

@Semos25
My dear, there will certainly be another opportunity. You can put it on the watch and wait for a correction

••

Tenbagger2024@Tenbagger2024

1D

@Semos25
Are you in the green with applovin?

••

1D

@Tenbagger2024 in between yes and now red again

••

Tenbagger2024@Tenbagger2024

1D

@Semos25
But she'll be back. You've already done well

••

1D

@Tenbagger2024 Let's see what happens

•

1

•

Join the conversation